Ohcanbohtosat - Ivan Bobkov

  • Čájehuvvo 1 - 2 / 2
Aiddostahte ozu
  1. 1
    Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?

    Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range? Dahkki Maciej Kabat, Ivan Bobkov, Suneel Kumar, Martin Grumet

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Iron-sulfur cluster proteins present the weak spot in non-thermal plasma-treated Escherichia coli

    Iron-sulfur cluster proteins present the weak spot in non-thermal plasma-treated Escherichia coli Dahkki Marco Krewing, Kim Marie Weisgerber, Tim Dirks, Ivan Bobkov, Britta Schubert, Julia E. Bandow

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: